DiaMedica Therapeutics Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $5.1M | $4.9M | $15.6M | $3.3M | $4.1M | $2.6M | $3.0M | $4.1M |
| Accounts Receivable | $244.0K | $301.0K | $258.0K | $260.0K | $161.0K | $253.0K | $236.0K | $290.0K |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $44.3M | $52.4M | $60.6M | $56.2M | $31.1M | $37.4M | $44.6M | $50.8M |
| Property, Plant & Equipment | $133.0K | $142.0K | $145.0K | $150.0K | $152.0K | $149.0K | $148.0K | $151.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $45.0M | $53.1M | $61.4M | $57.0M | $31.5M | $38.8M | $46.3M | $52.5M |
| Liabilities | ||||||||
| Accounts Payable | $2.8M | $3.3M | $1.5M | $1.9M | $1.3M | $1.5M | $940.0K | $1.2M |
| Total Current Liabilities | $6.6M | $5.7M | $5.1M | $5.3M | $4.1M | $4.7M | $5.4M | $4.3M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $6.7M | $5.8M | $5.3M | $5.4M | $4.3M | $4.9M | $5.6M | $4.6M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-192.9M | $-182.8M | $-172.8M | $-164.0M | $-155.4M | $-147.7M | $-140.0M | $-132.1M |
| Total Stockholders' Equity | $38.3M | $47.2M | $56.1M | $51.6M | $27.2M | $34.0M | $40.7M | $48.0M |